Home > Boards > Free Zone > User's Groups > Canadian Stocks: Current Trends and Chart Analysis

ADK.V - Moved from .39 to .51 last

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
december Member Profile
 
Followed By 69
Posts 12,699
Boards Moderated 1
Alias Born 12/10/04
160x600 placeholder
Top Stories of the Day
TOP STORIES Premier Foods Shares Seen as Undervalued -- Market Talk
Top Company News of the Day
Corn Futures Falls as Rainfall is Expected -- Daily Grain Highlights
Front Month Nymex Natural Gas Rose 10.51% This Week to Settle at $4.0600 -- Data Talk
Front Month Nymex RBOB Gasoline Rose 1.67% This Week to Settle at $2.2913 -- Data Talk
Grimmway Farms Recalls Certain Carrots Due to Risk of Salmonella
Kimberly-Clark Reports 2Q Results, Offers Guidance -- Commodity Comment
GDP Growth Expected to Accelerate in 2Q -- Data Week Ahead
Veoneer Shares Touch 52-week High, Magna Plans to Acquire Co.
AbbVie Gets FDA OK for Pediatric Skin Infection Drug
FTSE 100 Index Ends the Week 0.28% Higher at 7027.58 -- Data Talk
STOXX Europe 50 Index Ends the Week 0.84% Higher at 3558.08 -- Data Talk
CAC 40 Index Ends the Week 1.68% Higher at 6568.82 -- Data Talk
DAX Ends the Week 0.83% Higher at 15669.29 -- Data Talk
STOXX Europe 600 Index Ends the Week 1.49% Higher at 461.51 -- Data Talk
EURO STOXX 50 Index Ends the Week 1.82% Higher at 4109.10 -- Data Talk
FTSE 100 Closed Higher Despite Volatile Week
Vonovia Unlikely to Secure Enough Support From Deutsche Wohnen Shareholders to Pursue Takeover
Kimberly-Clark Keeps Forecast of Favorable FX in 2021 -- Currency Comment
U.S. Economic Growth Moderated in July -- IHS Markit
Veoneer Shares Climb on Magna Acquisition Deal
FTSE Rises, Covid-19 Strategy and Brexit Tensions Could Hit Pound
AstraZeneca's Bydureon BCise Gets U.S. Approval For Type 2 Diabetes in Pediatric Patients
december   Sunday, 11/18/07 04:05:07 PM
Re: TA4U post# 1711
Post # of 1730 
ADK.V - Moved from .39 to .51 last week on strong volume

Diagnos to analyze mining data for Everton
2007-11-13 10:18 ET - News Release
Also News Release (C-EVR) Everton Resources Inc

Mr. Andre Larente of Diagnos reports
DIAGNOS AND EVERTON RESOURCES SIGN A STRATEGIC AGREEMENT FOR A MAJOR PROJECT IN MINING EXPLORATION
Diagnos Inc. has signed a service agreement for a large targeting project with Everton Resources Inc., a Canadian exploration mining company which owns key properties in the Dominican Republic and the province of Quebec, Canada. Diagnos will use its CARDS (computer-aided resource detection software) system on the data provided by Everton Resources with the aim of identifying targets for precious and base metals on a territory covering many tens of thousands of square kilometres.
The highlights of this agreement are as follows.
Everton will pay Diagnos an amount of $175,000 in cash and will grant 50,000 common shares which value should not be under 80 cents each on the day of the grant. In the event of this case, Everton will grant the equivalent of $40,000 of shares.
These amounts are versed for consulting fees and for Everton to acquire a territorial exclusiveness in acquisition of titles, companies and in partnership development for a two-year period after the remittal of the report. At the end of these two years, Diagnos could decide to develop business partnerships on the basis of the results of the targeted zone.
A 2-per-cent net smelter return royalty will also be paid to Diagnos for each economical discovery on the studied zone. Everton Resources will have the option to acquire 1 per cent of this NSR for $1-million at all times.
The limit delivery date of the final report is Jan. 30, 2008.

Live for Today - Learn for Tomorrow
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences